Form 8-K - Current report:
SEC Accession No. 0001104659-23-048708
Filing Date
2023-04-24
Accepted
2023-04-24 08:44:35
Documents
12
Period of Report
2023-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313469d1_8k.htm   iXBRL 8-K 26326
  Complete submission text file 0001104659-23-048708.txt   199326

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fold-20230418.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20230418_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20230418_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2313469d1_8k_htm.xml XML 3482
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 23838022
SIC: 2834 Pharmaceutical Preparations